Investing Profile

Noubar Afeyan

VC
Photo of Noubar Afeyan, Managing Partner at Flagship Ventures
Your Intro Paths to Noubar Afeyan

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Noubar is a member of
Massachusetts Institute of Technology Network
176 CONNECTIONS
McGill University Network
41 CONNECTIONS
Flagship Pioneering Network
20 CONNECTIONS

Find Noubar Afeyan on

cb
Current Investing Position
Flagship Ventures Managing Partner
Investments On Record
50
Current Fund Size
$824M

Noubar Afeyan is on these Sector & Stage Rankings

Noubar Afeyan's Investments On Record (25)

CompanyStageDateRound SizeTotal Raised
Prologue Medicines
Series AMay 2024$50M
$50M
Co-investors: Lovisa Afzelius (Flagship Pioneering)
Quotient Therapeutics
SeedNov 2023$50M
$50M
Co-investors: Jacob Rubens (Flagship Pioneering), Geoffrey von Maltzahn (Flagship Pioneering)
Generate Biomedicines
Series CSep 2023$270M
Series BNov 2021$370M
$640M
Co-investors: Michael Nally (Flagship Pioneering), Geoffrey von Maltzahn (Flagship Pioneering), David Beazley (Alumni Ventures )
Alltrna
Series BAug 2023$110M
Series UnknownNov 2021$50M
$160M
Co-investors: Lovisa Afzelius (Flagship Pioneering)
Empress Therapeutics
Series UnknownJun 2023$50M
$50M
Co-investors: Doug Cole (Flagship Ventures)
Metaphore Biotechnologies
UndisclosedMay 2023$50M
$50M
Co-investors: Lovisa Afzelius (Flagship Pioneering)
Cellarity
Series COct 2022$120M
Series BFeb 2021$120M
$240M
Co-investors: Stephen Berenson (Flagship Pioneering)
Senda Biosciences
Series CAug 2022$120M
Series AOct 2020$88M
$210M
Co-investors: Guillaume Pfefer (Flagship Pioneering), Ignacio Martinez (Flagship Ventures)

Noubar Afeyan's Experience

Co-Founder Indigo2013 - Present
Chairman and Co-Founder Moderna Therapeutics2010 - Present
Chairman and Co-Founder Axcella Health2010 - Present
Founder, CEO and Senior Managing Partner Flagship Pioneering2000 - Present
Chairman and Co-Founder Joule Unlimited Technologies, Inc.2007 - 2017
Chairman and Co-Founder Ensemble Therapeutics Corporation2002 - 2016
Senior Lecturer MIT Sloan School of Management2000 - 2016
CEO and Founder PerSeptive Biosystems1989 - 2008
Chairman and Co-founder Codon Devices2004 - 2007
Co-founder Epitome Biosystems2003 - 2005
Chief Business Officer Applera Corporation1998 - 1999
Co-Founder Celera Genomics1998 - 1999
Chairman and Co-Founder Chemgenics Pharmaceuticals1995 - 1997

Noubar Afeyan's Education

Massachusetts Institute of Technology PhD Biochemical Engineering
McGill University BS Chemical Engineering